News & Events
European Patent Office revoked Regenlab PRP patent
Estar Medical has been successful in revoking Regenlab’s original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step…
TOBI 10th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs
Estar Medical is delighted to take part in the TOBI congress – a major yearly event for the international orthobiologics community…
FACE – Facial Aesthetic Conference & Exhibition, London, UK
Estar Medical is delighted to take part in the FACE conference and exhibition. UK’s premier conference for aesthetic medicine community…
UK High Court Refuses to Grant Regen Lab Permission to Appeal the PRP Patent Revocation Judgement
The UK Court refused to grant Regenlab permission to appeal the finding that its European PRP patent is invalid…
AMWC 17th Aesthetic & Anti-Aging Medicine World Congress
Estar medical is delighted to take part in the AMWC congress that has targeted effective aging…
IMCAS World Congress 2019 31 January – 2 February 2019 PARIS
Estar medical is delighted to take part in the IMCAS congress that has targeted effective aging…